Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Zuellig Pharma Announces Agreement with Regeneron to Introduce Libtayo®

Wednesday, August 28, 2024

Zuellig Pharma has entered into an exclusive distribution agreement with Regeneron Ireland DAC a subsidiary of Regeneron Pharmaceuticals IncLibtayo was developed using Regenerons VelocImmune technology and has received regulatory approval

Legend Biotech Secures Approval for Cilta-cel in China

Wednesday, August 28, 2024

Legend Biotech a subsidiary of GenScript Biotect has received approval from the China National Medical Products Administration NMPA for its cell therapy product ciltacabtagene autoleucel ciltacel

YolTech and Salubris Sign Agreement for YOLT-101 Development and Marketing in Mainland China

Wednesday, August 28, 2024

YolTech Therapeutics a leading clinicalstage gene editing company has signed an exclusive licensing agreement with Salubris Pharmaceuticals YOLT is a livertargeted base editing therapy currently being tested in an IIT clinical trial for patients with...

EU Approves Roche's PiaSky as First Monthly Subcutaneous Treatment for PNH

Tuesday, August 27, 2024

Roche announced that the European Commission has granted approval for PiaSky crovalimab a new monoclonal antibody that inhibits the complement protein C for treating adults and adolescents years and older weighing kg or more with paroxysmal nocturn...

Seegene Unveils mpox PCR Tests after WHO Health Emergency

Tuesday, August 27, 2024

Seegene announced the development of new PCR test assays in response to the World Health Organizations WHO recent declaration of mpox as a public health emergency of international concern PHEIC

EC Approves Celltrion's SteQeyma® Biosimilar for Chronic Inflammatory Diseases

Monday, August 26, 2024

Celltrion has announced that the European Commission EC has granted approval for SteQeyma CTP a biosimilar of ustekinumab referencing Stelara for the treatment of several chronic inflammatory conditions

Fujitsu Addresses ‘Drug Loss’ in Japan with New Ecosystem to Speed Up Clinical Trial Digitalisation

Monday, August 26, 2024

Fujitsu has announced plans to attract global clinical trials to Japan addressing the challenge of drug loss Fujitsu is collaborating with Paradigm Health to develop a new clinical trial data ecosystem in Japan By combining Paradigms global clinical...

GenFleet Announces Approval of KRAS G12C Inhibitor for Advanced Lung Cancer Treatment

Saturday, August 24, 2024

GenFleet Therapeutics has announced that Chinas National Medical Products Administration NMPA has approved Dupert fulzerasib GFHIBI for treating patients with advanced nonsmall cell lung cancer NSCLC with the KRAS GC mutation who have undergone at le...

Bridge Biotherapeutics and HitGen Collaborate on Novel Cancer Therapeutics

Friday, August 23, 2024

Bridge Biotherapeutics has entered into a joint research agreement with HitGen Building on the success of initial hit identification from HitGens DNAencoded library DEL the collaboration aims to advance these novel hits into promising drug candidates...

Clarity Receives FDA Fast Track Designation for 64Cu-SAR-bisPSMA

Friday, August 23, 2024

Clarity Pharmaceuticals has announced that the US Food and Drug Administration FDA has granted fast track designation for its CuSARbisPSMA a diagnostic agent designed for positron emission tomography PET imaging of prostatespecific membrane antigen P...